Intratympanic versus intravenous corticosteroid treatment for sudden sensorineural hearing loss in diabetic patients: proposed study protocol for a prospective, randomized superiority trial
Abstract Background Diabetes mellitus is associated with risk of sudden sensorineural hearing loss (SSNHL). Systemic and intratympanic corticosteroids are the two primary treatments for SSNHL in patients with diabetes mellitus. The benefit of intratympanic compared to systemic treatment is the reduc...
Main Authors: | Weiqiang Yang, Xiaoling Li, Jiatao Zhong, Xueshuang Mei, Hongyu Liu, Le Yang, Liming Lu, Hongyi Hu |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-02-01
|
Series: | Trials |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13063-020-4077-x |
Similar Items
-
Intratympanic Methylprednisolone Injection as First Line Therapy for Idiopathic Sudden Sensorineural Hearing Loss
by: Mukul Patar, et al.
Published: (2017-08-01) -
Intratympanic Methylprednisolone Injection as First Line Therapy for Idiopathic Sudden Sensorineural Hearing Loss
by: Mukul Patar, et al.
Published: (2017-08-01) -
Intratympanic dexamethasone injection vs methylprednisolone for the treatment of refractory sudden sensorineural hearing loss
by: Nezamoddin Berjis, et al.
Published: (2016-01-01) -
Intratympanic Steroids in Severe to Profound Sudden Sensorineural Hearing Loss as Salvage Treatment
by: Jong Dae Lee, et al.
Published: (2010-09-01) -
Combination of Pulse Steroid with Intratympanic Injections in Sudden Sensorineural Hearing Loss
by: Maryam Amizadeh, et al.
Published: (2021-01-01)